Cargando…
Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690902/ https://www.ncbi.nlm.nih.gov/pubmed/37470155 http://dx.doi.org/10.3324/haematol.2023.283566 |
| _version_ | 1785152621159383040 |
|---|---|
| author | Aldoss, Ibrahim Tizro, Parastou Bedi, Davsheen Mangan, James K. Clark, Mary C. Spencer, David Song, Joo Y. Cherian, Sindhu Pillai, Raju Kim, Young Mahajan, Nitin Gendzekhadze, Ketevan James, Mike Jacobs, Kenneth Davidson-Moncada, Jan Forman, Stephen J. Wang, HuanYou Afkhami, Michelle |
| author_facet | Aldoss, Ibrahim Tizro, Parastou Bedi, Davsheen Mangan, James K. Clark, Mary C. Spencer, David Song, Joo Y. Cherian, Sindhu Pillai, Raju Kim, Young Mahajan, Nitin Gendzekhadze, Ketevan James, Mike Jacobs, Kenneth Davidson-Moncada, Jan Forman, Stephen J. Wang, HuanYou Afkhami, Michelle |
| author_sort | Aldoss, Ibrahim |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10690902 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106909022023-12-02 Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia Aldoss, Ibrahim Tizro, Parastou Bedi, Davsheen Mangan, James K. Clark, Mary C. Spencer, David Song, Joo Y. Cherian, Sindhu Pillai, Raju Kim, Young Mahajan, Nitin Gendzekhadze, Ketevan James, Mike Jacobs, Kenneth Davidson-Moncada, Jan Forman, Stephen J. Wang, HuanYou Afkhami, Michelle Haematologica Case Report Fondazione Ferrata Storti 2023-07-20 /pmc/articles/PMC10690902/ /pubmed/37470155 http://dx.doi.org/10.3324/haematol.2023.283566 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Case Report Aldoss, Ibrahim Tizro, Parastou Bedi, Davsheen Mangan, James K. Clark, Mary C. Spencer, David Song, Joo Y. Cherian, Sindhu Pillai, Raju Kim, Young Mahajan, Nitin Gendzekhadze, Ketevan James, Mike Jacobs, Kenneth Davidson-Moncada, Jan Forman, Stephen J. Wang, HuanYou Afkhami, Michelle Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia |
| title | Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia |
| title_full | Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia |
| title_fullStr | Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia |
| title_full_unstemmed | Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia |
| title_short | Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia |
| title_sort | myeloid lineage switch following cd7-targeted chimeric antigen receptor t-cell therapy in relapsed/refractory t-cell acute lymphoblastic leukemia |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690902/ https://www.ncbi.nlm.nih.gov/pubmed/37470155 http://dx.doi.org/10.3324/haematol.2023.283566 |
| work_keys_str_mv | AT aldossibrahim myeloidlineageswitchfollowingcd7targetedchimericantigenreceptortcelltherapyinrelapsedrefractorytcellacutelymphoblasticleukemia AT tizroparastou myeloidlineageswitchfollowingcd7targetedchimericantigenreceptortcelltherapyinrelapsedrefractorytcellacutelymphoblasticleukemia AT bedidavsheen myeloidlineageswitchfollowingcd7targetedchimericantigenreceptortcelltherapyinrelapsedrefractorytcellacutelymphoblasticleukemia AT manganjamesk myeloidlineageswitchfollowingcd7targetedchimericantigenreceptortcelltherapyinrelapsedrefractorytcellacutelymphoblasticleukemia AT clarkmaryc myeloidlineageswitchfollowingcd7targetedchimericantigenreceptortcelltherapyinrelapsedrefractorytcellacutelymphoblasticleukemia AT spencerdavid myeloidlineageswitchfollowingcd7targetedchimericantigenreceptortcelltherapyinrelapsedrefractorytcellacutelymphoblasticleukemia AT songjooy myeloidlineageswitchfollowingcd7targetedchimericantigenreceptortcelltherapyinrelapsedrefractorytcellacutelymphoblasticleukemia AT cheriansindhu myeloidlineageswitchfollowingcd7targetedchimericantigenreceptortcelltherapyinrelapsedrefractorytcellacutelymphoblasticleukemia AT pillairaju myeloidlineageswitchfollowingcd7targetedchimericantigenreceptortcelltherapyinrelapsedrefractorytcellacutelymphoblasticleukemia AT kimyoung myeloidlineageswitchfollowingcd7targetedchimericantigenreceptortcelltherapyinrelapsedrefractorytcellacutelymphoblasticleukemia AT mahajannitin myeloidlineageswitchfollowingcd7targetedchimericantigenreceptortcelltherapyinrelapsedrefractorytcellacutelymphoblasticleukemia AT gendzekhadzeketevan myeloidlineageswitchfollowingcd7targetedchimericantigenreceptortcelltherapyinrelapsedrefractorytcellacutelymphoblasticleukemia AT jamesmike myeloidlineageswitchfollowingcd7targetedchimericantigenreceptortcelltherapyinrelapsedrefractorytcellacutelymphoblasticleukemia AT jacobskenneth myeloidlineageswitchfollowingcd7targetedchimericantigenreceptortcelltherapyinrelapsedrefractorytcellacutelymphoblasticleukemia AT davidsonmoncadajan myeloidlineageswitchfollowingcd7targetedchimericantigenreceptortcelltherapyinrelapsedrefractorytcellacutelymphoblasticleukemia AT formanstephenj myeloidlineageswitchfollowingcd7targetedchimericantigenreceptortcelltherapyinrelapsedrefractorytcellacutelymphoblasticleukemia AT wanghuanyou myeloidlineageswitchfollowingcd7targetedchimericantigenreceptortcelltherapyinrelapsedrefractorytcellacutelymphoblasticleukemia AT afkhamimichelle myeloidlineageswitchfollowingcd7targetedchimericantigenreceptortcelltherapyinrelapsedrefractorytcellacutelymphoblasticleukemia |